

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelial cell chemotaxis (GO:0035767) | 6.76969424 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.30593138 |
| 3 | regulation of gamma-delta T cell activation (GO:0046643) | 5.95491435 |
| 4 | NIK/NF-kappaB signaling (GO:0038061) | 5.81511093 |
| 5 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.51635743 |
| 6 | positive thymic T cell selection (GO:0045059) | 5.21768839 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.20138510 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.85649858 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.85649858 |
| 10 | response to peptidoglycan (GO:0032494) | 4.74411532 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66126263 |
| 12 | response to muramyl dipeptide (GO:0032495) | 4.52564804 |
| 13 | thymic T cell selection (GO:0045061) | 4.50740745 |
| 14 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 4.39828851 |
| 15 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.30175488 |
| 16 | positive T cell selection (GO:0043368) | 4.21435461 |
| 17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.10484724 |
| 18 | T cell selection (GO:0045058) | 4.04635517 |
| 19 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.97080991 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.90986557 |
| 21 | myeloid dendritic cell differentiation (GO:0043011) | 3.85142907 |
| 22 | negative T cell selection (GO:0043383) | 3.82232560 |
| 23 | T cell migration (GO:0072678) | 3.79554208 |
| 24 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.75933308 |
| 25 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.75933308 |
| 26 | modulation by symbiont of host immune response (GO:0052553) | 3.75933308 |
| 27 | positive regulation by symbiont of host defense response (GO:0052509) | 3.75933308 |
| 28 | modulation by symbiont of host defense response (GO:0052031) | 3.75933308 |
| 29 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.75933308 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.67549895 |
| 31 | interferon-gamma production (GO:0032609) | 3.65802800 |
| 32 | neutrophil activation involved in immune response (GO:0002283) | 3.65753781 |
| 33 | tolerance induction (GO:0002507) | 3.65135822 |
| 34 | response to interleukin-15 (GO:0070672) | 3.61964676 |
| 35 | detection of other organism (GO:0098543) | 3.61365197 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.58165049 |
| 37 | myeloid dendritic cell activation (GO:0001773) | 3.54730947 |
| 38 | cellular extravasation (GO:0045123) | 3.50700807 |
| 39 | positive regulation of interleukin-2 production (GO:0032743) | 3.40727214 |
| 40 | regulation of response to interferon-gamma (GO:0060330) | 3.39891744 |
| 41 | detection of bacterium (GO:0016045) | 3.39208018 |
| 42 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.37036399 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.36241765 |
| 44 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.35252482 |
| 45 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.34759106 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.32561818 |
| 47 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.30360385 |
| 48 | leukocyte aggregation (GO:0070486) | 3.28751302 |
| 49 | defense response to protozoan (GO:0042832) | 3.22356245 |
| 50 | response to protozoan (GO:0001562) | 3.21044037 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18234827 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17857774 |
| 53 | positive regulation of type 2 immune response (GO:0002830) | 3.13677088 |
| 54 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.13193250 |
| 55 | natural killer cell differentiation (GO:0001779) | 3.12264086 |
| 56 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09948403 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07316057 |
| 58 | T cell receptor signaling pathway (GO:0050852) | 3.04233178 |
| 59 | negative regulation of interleukin-6 production (GO:0032715) | 3.03581769 |
| 60 | granulocyte activation (GO:0036230) | 3.00808345 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00660367 |
| 62 | neutrophil activation (GO:0042119) | 2.99265812 |
| 63 | mature B cell differentiation (GO:0002335) | 2.98849727 |
| 64 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.98653651 |
| 65 | germinal center formation (GO:0002467) | 2.97896766 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 2.97812575 |
| 67 | T-helper cell differentiation (GO:0042093) | 2.97451553 |
| 68 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.97451553 |
| 69 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.96578022 |
| 70 | positive regulation of p38MAPK cascade (GO:1900745) | 2.95426233 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 2.95298271 |
| 72 | response to laminar fluid shear stress (GO:0034616) | 2.95181043 |
| 73 | detection of external biotic stimulus (GO:0098581) | 2.94829142 |
| 74 | response to type I interferon (GO:0034340) | 2.94411584 |
| 75 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.94039196 |
| 76 | positive regulation of humoral immune response (GO:0002922) | 2.93567956 |
| 77 | T-helper 1 type immune response (GO:0042088) | 2.92883320 |
| 78 | macrophage activation (GO:0042116) | 2.92440850 |
| 79 | blood vessel endothelial cell migration (GO:0043534) | 2.92246845 |
| 80 | type I interferon signaling pathway (GO:0060337) | 2.91466636 |
| 81 | cellular response to type I interferon (GO:0071357) | 2.91466636 |
| 82 | regulation of p38MAPK cascade (GO:1900744) | 2.90077389 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88759955 |
| 84 | detection of biotic stimulus (GO:0009595) | 2.87409053 |
| 85 | negative regulation of interleukin-8 production (GO:0032717) | 2.85202359 |
| 86 | interferon-gamma secretion (GO:0072643) | 2.81798432 |
| 87 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.80577877 |
| 88 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80140205 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80140205 |
| 90 | positive regulation of interleukin-12 production (GO:0032735) | 2.79567666 |
| 91 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79051348 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.76827194 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76752220 |
| 94 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.75517030 |
| 95 | positive regulation of B cell differentiation (GO:0045579) | 2.75363074 |
| 96 | neutrophil mediated immunity (GO:0002446) | 2.75213421 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75114390 |
| 98 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72719497 |
| 99 | dendritic cell differentiation (GO:0097028) | 2.71787391 |
| 100 | leukocyte cell-cell adhesion (GO:0007159) | 2.70877361 |
| 101 | regulation of mast cell degranulation (GO:0043304) | 2.70374465 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 2.69539363 |
| 103 | regulation of interferon-alpha production (GO:0032647) | 2.69439422 |
| 104 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.69129927 |
| 105 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68988886 |
| 106 | regulation of type 2 immune response (GO:0002828) | 2.68177394 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67612743 |
| 108 | regulation of chronic inflammatory response (GO:0002676) | 2.67477234 |
| 109 | embryonic process involved in female pregnancy (GO:0060136) | 2.67323766 |
| 110 | positive regulation of tolerance induction (GO:0002645) | 2.66445995 |
| 111 | regulation of germinal center formation (GO:0002634) | 2.65826512 |
| 112 | activation of MAPKKK activity (GO:0000185) | 2.64863702 |
| 113 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64269127 |
| 114 | growth hormone receptor signaling pathway (GO:0060396) | 2.63853119 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.63264362 |
| 116 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.63155096 |
| 117 | response to host immune response (GO:0052572) | 2.63155096 |
| 118 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.62795384 |
| 119 | lymphocyte homeostasis (GO:0002260) | 2.62213912 |
| 120 | regulation of interleukin-12 production (GO:0032655) | 2.62065955 |
| 121 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.61418524 |
| 122 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61335855 |
| 123 | JAK-STAT cascade (GO:0007259) | 2.61089457 |
| 124 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.60646682 |
| 125 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.60646682 |
| 126 | T cell differentiation involved in immune response (GO:0002292) | 2.60646682 |
| 127 | regulation of interleukin-2 production (GO:0032663) | 2.59779518 |
| 128 | regulation of T-helper cell differentiation (GO:0045622) | 2.59049497 |
| 129 | positive regulation of interferon-alpha production (GO:0032727) | 2.58292423 |
| 130 | regulation of B cell differentiation (GO:0045577) | 2.57882863 |
| 131 | positive regulation of T cell differentiation (GO:0045582) | 2.57546425 |
| 132 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57427320 |
| 133 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56740191 |
| 134 | modulation by symbiont of host cellular process (GO:0044068) | 2.56167546 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.55760721 |
| 136 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.55144761 |
| 137 | alpha-beta T cell differentiation (GO:0046632) | 2.54950765 |
| 138 | alpha-beta T cell activation (GO:0046631) | 2.54756125 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54167773 |
| 140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.54023865 |
| 141 | natural killer cell activation (GO:0030101) | 2.53442629 |
| 142 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.53289260 |
| 143 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.53236936 |
| 144 | response to host defenses (GO:0052200) | 2.53230967 |
| 145 | regulation of regulatory T cell differentiation (GO:0045589) | 2.53170813 |
| 146 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52813833 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52272170 |
| 148 | negative regulation of cell killing (GO:0031342) | 2.52272170 |
| 149 | immunoglobulin mediated immune response (GO:0016064) | 2.51879795 |
| 150 | establishment of endothelial barrier (GO:0061028) | 2.51755991 |
| 151 | regulation of thymocyte apoptotic process (GO:0070243) | 2.51506031 |
| 152 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.51203111 |
| 153 | regulation of tolerance induction (GO:0002643) | 2.50656620 |
| 154 | negative regulation of interleukin-12 production (GO:0032695) | 2.50087054 |
| 155 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.49300357 |
| 156 | lymphocyte migration (GO:0072676) | 2.47077016 |
| 157 | B cell receptor signaling pathway (GO:0050853) | 2.46730963 |
| 158 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.45464227 |
| 159 | T cell differentiation (GO:0030217) | 2.45064701 |
| 160 | T cell costimulation (GO:0031295) | 2.44198130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.35156418 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.10517970 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.64466932 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.17854501 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.52158090 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.28269030 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.10313383 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.03194103 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.86612686 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.81810192 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.79130480 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77400582 |
| 13 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.60422079 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.58436657 |
| 15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.49338585 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.41047160 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39676992 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.38507339 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.37424936 |
| 20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.34655255 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.33890495 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29665735 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29623174 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20776608 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.19043056 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18975747 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.18144993 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14778118 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.14544788 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12884133 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.12060638 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08968804 |
| 33 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04527952 |
| 34 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01081265 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95911917 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.94713494 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.93981799 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.85848597 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82538191 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82160061 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.65611291 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65285623 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64042450 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.60447230 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.57965908 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51941318 |
| 47 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48677718 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43684067 |
| 49 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40519496 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.34937648 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34267447 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.30070817 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25858397 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24890697 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23494574 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23444625 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20948783 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20727298 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20724459 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20103237 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18403446 |
| 62 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.17798121 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17404018 |
| 64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17346034 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17246693 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15493252 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14814757 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12961726 |
| 69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12538946 |
| 70 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12110386 |
| 71 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.11097505 |
| 72 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10600114 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09909327 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09282181 |
| 75 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09119146 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08660870 |
| 77 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08609175 |
| 78 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.07833967 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07769728 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06319157 |
| 81 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04866329 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04280354 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04056870 |
| 84 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03946273 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03300860 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01616518 |
| 87 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01375940 |
| 88 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01375940 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00044179 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99921974 |
| 91 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99886962 |
| 92 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99587150 |
| 93 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99507208 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97961927 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97679004 |
| 96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97501599 |
| 97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97424096 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96494610 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95545889 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94058623 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92649649 |
| 102 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92548382 |
| 103 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.91893335 |
| 104 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.91893335 |
| 105 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.91893335 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91691026 |
| 107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91436152 |
| 108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90856970 |
| 109 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90588400 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90062844 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89843541 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89144893 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89135251 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88710290 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88283216 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87532580 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86963656 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86190394 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85451754 |
| 120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83179474 |
| 121 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.82806596 |
| 122 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82515926 |
| 123 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.82379393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.81361906 |
| 2 | MP0003303_peritoneal_inflammation | 3.54981079 |
| 3 | MP0000685_abnormal_immune_system | 3.20624233 |
| 4 | MP0003436_decreased_susceptibility_to | 3.16105092 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.16048956 |
| 6 | MP0001790_abnormal_immune_system | 2.79207300 |
| 7 | MP0005387_immune_system_phenotype | 2.79207300 |
| 8 | MP0003724_increased_susceptibility_to | 2.74633163 |
| 9 | MP0001800_abnormal_humoral_immune | 2.73535111 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.68713808 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.62147495 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.42454481 |
| 13 | MP0004947_skin_inflammation | 2.39969047 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.38920906 |
| 15 | MP0009278_abnormal_bone_marrow | 2.38808224 |
| 16 | MP0001853_heart_inflammation | 2.37531269 |
| 17 | MP0002723_abnormal_immune_serum | 2.36946748 |
| 18 | MP0002405_respiratory_system_inflammati | 2.36221496 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.31618028 |
| 20 | MP0005671_abnormal_response_to | 2.18852764 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.17151755 |
| 22 | MP0001819_abnormal_immune_cell | 2.15997964 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 2.13964643 |
| 24 | MP0009785_altered_susceptibility_to | 2.07799065 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.04972454 |
| 26 | MP0002398_abnormal_bone_marrow | 2.01741722 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.96740788 |
| 28 | MP0008004_abnormal_stomach_pH | 1.96231842 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.93163613 |
| 30 | MP0002419_abnormal_innate_immunity | 1.93020671 |
| 31 | MP0001851_eye_inflammation | 1.92421415 |
| 32 | MP0005025_abnormal_response_to | 1.90604855 |
| 33 | MP0001873_stomach_inflammation | 1.89320325 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.88383419 |
| 35 | MP0000716_abnormal_immune_system | 1.82459733 |
| 36 | MP0002254_reproductive_system_inflammat | 1.82113979 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.76728373 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.67920782 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.66642713 |
| 40 | MP0002722_abnormal_immune_system | 1.66537033 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.65135121 |
| 42 | MP0001545_abnormal_hematopoietic_system | 1.63960120 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.63960120 |
| 44 | MP0002006_tumorigenesis | 1.61233278 |
| 45 | MP0002933_joint_inflammation | 1.60109296 |
| 46 | MP0003866_abnormal_defecation | 1.58727630 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.58183474 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.57920061 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.57864266 |
| 50 | MP0003828_pulmonary_edema | 1.57765553 |
| 51 | MP0005451_abnormal_body_composition | 1.56281044 |
| 52 | MP0002396_abnormal_hematopoietic_system | 1.54474226 |
| 53 | MP0006082_CNS_inflammation | 1.52256910 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.50130819 |
| 55 | MP0002429_abnormal_blood_cell | 1.48721592 |
| 56 | MP0005310_abnormal_salivary_gland | 1.47381406 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.45475767 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.40666905 |
| 59 | MP0003453_abnormal_keratinocyte_physiol | 1.37442814 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.36358182 |
| 61 | MP0003448_altered_tumor_morphology | 1.36164288 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.30638064 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.29011906 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.26504171 |
| 65 | MP0005023_abnormal_wound_healing | 1.21959181 |
| 66 | MP0002132_abnormal_respiratory_system | 1.18600538 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.17213052 |
| 68 | MP0003091_abnormal_cell_migration | 1.15689467 |
| 69 | MP0009840_abnormal_foam_cell | 1.13285289 |
| 70 | MP0008260_abnormal_autophagy | 1.11909128 |
| 71 | MP0000490_abnormal_crypts_of | 1.07474336 |
| 72 | MP0000858_altered_metastatic_potential | 1.07066538 |
| 73 | MP0010307_abnormal_tumor_latency | 1.03149913 |
| 74 | MP0003705_abnormal_hypodermis_morpholog | 1.02875599 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.98608619 |
| 76 | MP0002009_preneoplasia | 0.98490748 |
| 77 | MP0000249_abnormal_blood_vessel | 0.96712479 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 0.96157727 |
| 79 | MP0008469_abnormal_protein_level | 0.94249663 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.91866138 |
| 81 | * MP0005390_skeleton_phenotype | 0.89634749 |
| 82 | MP0001216_abnormal_epidermal_layer | 0.87809904 |
| 83 | MP0000604_amyloidosis | 0.86975026 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.85924393 |
| 85 | MP0000733_abnormal_muscle_development | 0.80071169 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.79776821 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.79154119 |
| 88 | MP0001243_abnormal_dermal_layer | 0.79130246 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.77490447 |
| 90 | MP0003075_altered_response_to | 0.77229303 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.76406884 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.75968633 |
| 93 | MP0005166_decreased_susceptibility_to | 0.75651615 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.74998549 |
| 95 | MP0003795_abnormal_bone_structure | 0.74438722 |
| 96 | MP0000609_abnormal_liver_physiology | 0.72866203 |
| 97 | MP0004381_abnormal_hair_follicle | 0.72640902 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.71508155 |
| 99 | MP0003045_fibrosis | 0.71035693 |
| 100 | MP0003690_abnormal_glial_cell | 0.70821949 |
| 101 | MP0000343_altered_response_to | 0.70311228 |
| 102 | MP0002060_abnormal_skin_morphology | 0.69591277 |
| 103 | MP0001663_abnormal_digestive_system | 0.68698733 |
| 104 | MP0001542_abnormal_bone_strength | 0.68206501 |
| 105 | MP0000767_abnormal_smooth_muscle | 0.67351108 |
| 106 | MP0008995_early_reproductive_senescence | 0.67350987 |
| 107 | MP0008057_abnormal_DNA_replication | 0.65288992 |
| 108 | MP0009764_decreased_sensitivity_to | 0.64679656 |
| 109 | MP0004883_abnormal_blood_vessel | 0.64638494 |
| 110 | MP0005165_increased_susceptibility_to | 0.64460063 |
| 111 | MP0001191_abnormal_skin_condition | 0.63653297 |
| 112 | MP0005535_abnormal_body_temperature | 0.62237833 |
| 113 | MP0009931_abnormal_skin_appearance | 0.61705507 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.61527477 |
| 115 | MP0009115_abnormal_fat_cell | 0.60776498 |
| 116 | MP0009763_increased_sensitivity_to | 0.58010518 |
| 117 | MP0003279_aneurysm | 0.57420906 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.56554817 |
| 119 | MP0005164_abnormal_response_to | 0.56073128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 5.11662113 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.55150184 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.53012484 |
| 4 | Abnormality of the nasal mucosa (HP:0000433) | 4.20120124 |
| 5 | Nasal polyposis (HP:0100582) | 4.15427713 |
| 6 | Myositis (HP:0100614) | 4.05581110 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.82801892 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.66129421 |
| 9 | Orchitis (HP:0100796) | 3.63180197 |
| 10 | Chronic otitis media (HP:0000389) | 3.61058452 |
| 11 | Cellulitis (HP:0100658) | 3.56918498 |
| 12 | Persistence of primary teeth (HP:0006335) | 3.56573184 |
| 13 | Increased density of long bones (HP:0006392) | 3.44578750 |
| 14 | Optic neuritis (HP:0100653) | 3.40311623 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.40311623 |
| 16 | Recurrent viral infections (HP:0004429) | 3.36499666 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.32964105 |
| 18 | IgM deficiency (HP:0002850) | 3.30004919 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.14489402 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13226040 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.09026618 |
| 22 | T lymphocytopenia (HP:0005403) | 3.08694681 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.05350271 |
| 24 | Increased IgE level (HP:0003212) | 3.04132304 |
| 25 | Pustule (HP:0200039) | 3.03013466 |
| 26 | Hematochezia (HP:0002573) | 2.96475727 |
| 27 | Vasculitis (HP:0002633) | 2.96305165 |
| 28 | Amyloidosis (HP:0011034) | 2.92866830 |
| 29 | Myocardial infarction (HP:0001658) | 2.92752392 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.89373540 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.88534166 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 2.82360536 |
| 33 | Dysostosis multiplex (HP:0000943) | 2.80269562 |
| 34 | Recurrent bacterial skin infections (HP:0005406) | 2.79536374 |
| 35 | Arterial thrombosis (HP:0004420) | 2.79016864 |
| 36 | Emphysema (HP:0002097) | 2.77838687 |
| 37 | Abnormality of T cells (HP:0002843) | 2.75183270 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.74830790 |
| 39 | Leukocytosis (HP:0001974) | 2.70806220 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.70685499 |
| 41 | Eosinophilia (HP:0001880) | 2.66789510 |
| 42 | Autoimmune hemolytic anemia (HP:0001890) | 2.65960736 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.60616678 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.60616678 |
| 45 | Gangrene (HP:0100758) | 2.60026648 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 2.59950727 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59864094 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.54975790 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.54975790 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.54975790 |
| 51 | Encephalitis (HP:0002383) | 2.54894523 |
| 52 | Episodic fever (HP:0001954) | 2.54329478 |
| 53 | Abnormality of eosinophils (HP:0001879) | 2.54027646 |
| 54 | B lymphocytopenia (HP:0010976) | 2.51270744 |
| 55 | Abnormality of B cell number (HP:0010975) | 2.51270744 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.49921735 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.48959803 |
| 58 | Aortic aneurysm (HP:0004942) | 2.43129259 |
| 59 | Meningitis (HP:0001287) | 2.42418910 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.41339032 |
| 61 | Combined immunodeficiency (HP:0005387) | 2.40899113 |
| 62 | Urticaria (HP:0001025) | 2.40222333 |
| 63 | Hemoptysis (HP:0002105) | 2.40048744 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.36680540 |
| 65 | Polycythemia (HP:0001901) | 2.35885117 |
| 66 | Colitis (HP:0002583) | 2.35646219 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.35482001 |
| 68 | Spondylolisthesis (HP:0003302) | 2.34443852 |
| 69 | Lymphopenia (HP:0001888) | 2.34308187 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.33945244 |
| 71 | Stomach cancer (HP:0012126) | 2.33808884 |
| 72 | Thrombocytosis (HP:0001894) | 2.32890759 |
| 73 | Thyroiditis (HP:0100646) | 2.31536955 |
| 74 | IgG deficiency (HP:0004315) | 2.30912302 |
| 75 | Recurrent skin infections (HP:0001581) | 2.30871518 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30824980 |
| 77 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.30560288 |
| 78 | Gastrointestinal inflammation (HP:0004386) | 2.25775728 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.25556102 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.24999240 |
| 81 | Alveolar cell carcinoma (HP:0006519) | 2.22863655 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.22340803 |
| 83 | Bronchitis (HP:0012387) | 2.21557089 |
| 84 | Loss of speech (HP:0002371) | 2.20825425 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18235270 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18235270 |
| 87 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18235270 |
| 88 | Gastrointestinal stroma tumor (HP:0100723) | 2.18190147 |
| 89 | Glomerulopathy (HP:0100820) | 2.17542539 |
| 90 | Increased serum ferritin (HP:0003281) | 2.14488532 |
| 91 | Restrictive lung disease (HP:0002091) | 2.13854811 |
| 92 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.13057816 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.13057816 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.12270607 |
| 95 | Epistaxis (HP:0000421) | 2.10869734 |
| 96 | Granulocytopenia (HP:0001913) | 2.10636785 |
| 97 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10214806 |
| 98 | Papilloma (HP:0012740) | 2.09420597 |
| 99 | Verrucae (HP:0200043) | 2.09420597 |
| 100 | Recurrent sinusitis (HP:0011108) | 2.08180088 |
| 101 | Abnormal platelet function (HP:0011869) | 2.07754531 |
| 102 | Impaired platelet aggregation (HP:0003540) | 2.07754531 |
| 103 | Increased CSF protein (HP:0002922) | 2.07705764 |
| 104 | Gingivitis (HP:0000230) | 2.07300029 |
| 105 | IgA deficiency (HP:0002720) | 2.06647584 |
| 106 | Gingival bleeding (HP:0000225) | 2.05865501 |
| 107 | Pulmonary embolism (HP:0002204) | 2.05805402 |
| 108 | Joint swelling (HP:0001386) | 2.05221086 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 2.03617675 |
| 110 | Mitral valve prolapse (HP:0001634) | 2.03426328 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01785163 |
| 112 | Osteolytic defects of the hand bones (HP:0009699) | 2.01785163 |
| 113 | Esophageal varix (HP:0002040) | 2.01746856 |
| 114 | Prolonged bleeding time (HP:0003010) | 2.01029373 |
| 115 | Vertigo (HP:0002321) | 2.00898454 |
| 116 | Chronic diarrhea (HP:0002028) | 2.00779440 |
| 117 | Chronic sinusitis (HP:0011109) | 1.99938221 |
| 118 | Increased IgM level (HP:0003496) | 1.98077219 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.97092219 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.95520215 |
| 121 | Fatigue (HP:0012378) | 1.94200799 |
| 122 | Osteomyelitis (HP:0002754) | 1.94153280 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93795067 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.93626905 |
| 125 | Arthralgia (HP:0002829) | 1.93388441 |
| 126 | Thick nail (HP:0001805) | 1.93130477 |
| 127 | Disproportionate tall stature (HP:0001519) | 1.92679527 |
| 128 | Polyneuropathy (HP:0001271) | 1.90990053 |
| 129 | Anorexia (HP:0002039) | 1.90907578 |
| 130 | Skin ulcer (HP:0200042) | 1.90775562 |
| 131 | Sepsis (HP:0100806) | 1.89964954 |
| 132 | Obstructive sleep apnea (HP:0002870) | 1.89430339 |
| 133 | Chest pain (HP:0100749) | 1.87043156 |
| 134 | Peripheral hypomyelination (HP:0007182) | 1.86965856 |
| 135 | Lymphoma (HP:0002665) | 1.85939834 |
| 136 | Abnormality of the pericardium (HP:0001697) | 1.85720908 |
| 137 | Obstructive lung disease (HP:0006536) | 1.84822428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.92472683 |
| 2 | PRPF4B | 3.59680575 |
| 3 | MAP3K14 | 3.53485589 |
| 4 | EEF2K | 3.30801443 |
| 5 | MAP3K10 | 3.24570122 |
| 6 | TXK | 3.08633844 |
| 7 | RIPK4 | 2.76203814 |
| 8 | TBK1 | 2.49300611 |
| 9 | IKBKB | 2.45059358 |
| 10 | TGFBR2 | 2.35070815 |
| 11 | EPHB1 | 2.27697589 |
| 12 | STK10 | 2.24024013 |
| 13 | IKBKE | 2.21443417 |
| 14 | CHUK | 2.19126715 |
| 15 | JAK3 | 2.13745455 |
| 16 | FGFR4 | 2.08641953 |
| 17 | TYK2 | 2.07921961 |
| 18 | ZAP70 | 1.91673262 |
| 19 | EPHA3 | 1.90495639 |
| 20 | BMPR2 | 1.90122114 |
| 21 | ERN1 | 1.85980456 |
| 22 | NLK | 1.82791119 |
| 23 | PIM1 | 1.76822072 |
| 24 | MAP3K3 | 1.76303745 |
| 25 | TAOK2 | 1.74554288 |
| 26 | RPS6KA4 | 1.74046044 |
| 27 | ITK | 1.67705829 |
| 28 | GRK6 | 1.66834974 |
| 29 | TRIB3 | 1.66569246 |
| 30 | IRAK2 | 1.62823827 |
| 31 | MAP2K3 | 1.62374727 |
| 32 | IRAK3 | 1.57565878 |
| 33 | JAK1 | 1.46343386 |
| 34 | CDK12 | 1.43791721 |
| 35 | MAPK15 | 1.34626787 |
| 36 | PIM2 | 1.34211817 |
| 37 | RPS6KA5 | 1.29161154 |
| 38 | FGFR3 | 1.28659079 |
| 39 | TSSK6 | 1.20709658 |
| 40 | HCK | 1.15488295 |
| 41 | BTK | 1.12557890 |
| 42 | MATK | 1.10405699 |
| 43 | RIPK1 | 1.09923282 |
| 44 | MARK3 | 1.09444363 |
| 45 | MAP3K11 | 1.09430979 |
| 46 | TNK2 | 1.07787016 |
| 47 | LCK | 1.07009632 |
| 48 | MARK2 | 1.03903460 |
| 49 | PKN2 | 1.02509912 |
| 50 | TEC | 1.01612205 |
| 51 | TIE1 | 1.00373675 |
| 52 | DMPK | 0.99254343 |
| 53 | CSK | 0.98384586 |
| 54 | MOS | 0.98121114 |
| 55 | MST4 | 0.95469660 |
| 56 | PTK6 | 0.93556623 |
| 57 | TAOK3 | 0.93030693 |
| 58 | MAPK12 | 0.92850519 |
| 59 | LRRK2 | 0.91446046 |
| 60 | GRK7 | 0.90702235 |
| 61 | CDC42BPA | 0.87472899 |
| 62 | JAK2 | 0.86941927 |
| 63 | KDR | 0.85601853 |
| 64 | MAP3K13 | 0.82421796 |
| 65 | HIPK2 | 0.81869715 |
| 66 | RPS6KA1 | 0.81009567 |
| 67 | MAP2K2 | 0.79998707 |
| 68 | SYK | 0.79678748 |
| 69 | CLK1 | 0.77643449 |
| 70 | RPS6KL1 | 0.75575020 |
| 71 | RPS6KC1 | 0.75575020 |
| 72 | TAOK1 | 0.75345191 |
| 73 | TGFBR1 | 0.74574683 |
| 74 | PDK2 | 0.72709923 |
| 75 | PDGFRB | 0.71425037 |
| 76 | KIT | 0.69766771 |
| 77 | BMX | 0.69002382 |
| 78 | GSK3A | 0.68936968 |
| 79 | PDK1 | 0.68144754 |
| 80 | IRAK1 | 0.67377980 |
| 81 | BRD4 | 0.65932321 |
| 82 | CSF1R | 0.64343870 |
| 83 | MAPKAPK2 | 0.64041445 |
| 84 | IRAK4 | 0.63535532 |
| 85 | TTN | 0.62516840 |
| 86 | NME2 | 0.62268825 |
| 87 | TRPM7 | 0.60382140 |
| 88 | PDPK1 | 0.60238930 |
| 89 | RPS6KA2 | 0.60177607 |
| 90 | MELK | 0.59999710 |
| 91 | BLK | 0.58965263 |
| 92 | FGR | 0.57136473 |
| 93 | MAP3K1 | 0.56973903 |
| 94 | CDK9 | 0.55221588 |
| 95 | MAPK7 | 0.53660316 |
| 96 | TESK2 | 0.53555704 |
| 97 | SIK1 | 0.53481661 |
| 98 | PIK3CG | 0.52429809 |
| 99 | KSR2 | 0.51723727 |
| 100 | ALK | 0.51286062 |
| 101 | CDK4 | 0.48068606 |
| 102 | RPS6KA6 | 0.47520659 |
| 103 | PAK2 | 0.46995106 |
| 104 | SIK2 | 0.46606653 |
| 105 | MTOR | 0.45650019 |
| 106 | MAP3K7 | 0.43150827 |
| 107 | MAPK3 | 0.43061339 |
| 108 | EPHA2 | 0.42920071 |
| 109 | MAP3K6 | 0.42210116 |
| 110 | MAPK4 | 0.41940284 |
| 111 | PRKCH | 0.41603214 |
| 112 | RPS6KB2 | 0.40898901 |
| 113 | MAP3K5 | 0.40554580 |
| 114 | SIK3 | 0.40425133 |
| 115 | SGK3 | 0.39125629 |
| 116 | DYRK1B | 0.35338352 |
| 117 | MAP3K8 | 0.35201452 |
| 118 | PRKCQ | 0.34957767 |
| 119 | PRKD2 | 0.33979936 |
| 120 | STK11 | 0.33830392 |
| 121 | MAPK11 | 0.33629092 |
| 122 | LYN | 0.32818546 |
| 123 | ICK | 0.32805192 |
| 124 | CDK6 | 0.31977393 |
| 125 | ABL1 | 0.31633266 |
| 126 | MAPK1 | 0.31248269 |
| 127 | STK24 | 0.30863936 |
| 128 | FES | 0.30838081 |
| 129 | INSR | 0.30826237 |
| 130 | STK4 | 0.30215548 |
| 131 | STK3 | 0.28549778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12276879 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.03094870 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74694802 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54686066 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41622761 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.41130020 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.32898264 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.24534501 |
| 9 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.18023154 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02226929 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.98142182 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95553228 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.94033482 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.88612557 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.85293829 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83733935 |
| 17 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.71504969 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.64911081 |
| 19 | Apoptosis_Homo sapiens_hsa04210 | 1.63312176 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61382225 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.59800931 |
| 22 | Hepatitis B_Homo sapiens_hsa05161 | 1.55475456 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55392998 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.55359831 |
| 25 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.55179232 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54893369 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.53432558 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.53267793 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.44567522 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.42990534 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42232016 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33072265 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32996833 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31178564 |
| 35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.27850486 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.25871376 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19754333 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18481764 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.18302907 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.16526129 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15731571 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.14233834 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13271664 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12676896 |
| 45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11687095 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06223772 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05948379 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04801999 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01638079 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01325816 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.00158118 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99911090 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98408852 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97559544 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97185950 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.97090409 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.96644519 |
| 58 | Tuberculosis_Homo sapiens_hsa05152 | 0.96531927 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.95587754 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94794523 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.91493600 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.90628110 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87553756 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85739169 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84906868 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.82772394 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.80105563 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79792451 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79011946 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77538255 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.77058913 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77051493 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.75618381 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72491749 |
| 75 | Prostate cancer_Homo sapiens_hsa05215 | 0.69895422 |
| 76 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69701225 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.67607997 |
| 78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66231782 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65998836 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63145463 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60180173 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59373801 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59031942 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.58487086 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.58408319 |
| 86 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56828568 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54988244 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54906529 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53623729 |
| 90 | Adherens junction_Homo sapiens_hsa04520 | 0.51511676 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51500233 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51135259 |
| 93 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49756633 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49158968 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48843464 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47646653 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47486460 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47236927 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.47038499 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46825463 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43651203 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.43469980 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42701210 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42418480 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41809934 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40830407 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38682219 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37867744 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.37395561 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.37153258 |
| 111 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37072221 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34784002 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34033927 |

